Luciana Giodini

Clinical validity of a <scp><i>DPYD</i></scp>‐based pharmacogenetic test to predict severe toxicity to fluoropyrimidines

Giuseppe Toffoli, Luciana Giodini, Angela Buonadonna et al. · International Journal of Cancer · 2015 · 90 citations · Full text

Cancer Pathology, Genetic Epidemiology, Pathology +28

Development and validation of a HPLC-UV method for the quantification of antiepileptic drugs in dried plasma spots

Sara Baldelli, Dario Cattaneo, Luciana Giodini et al. · Clinical Chemistry and Laboratory Medicine (CCLM) · 2014 · 50 citations

Candidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma

Claudia Maria Hattinger, Paola Biason, Erika Iacoboni et al. · Oncotarget · 2016 · 46 citations · Full text

Candidate Germline Polymorphisms, Surgery.germline Polymorphisms, Health Sciences +15

Cost Evaluation of Irinotecan‐Related Toxicities Associated With the <i>UGT1A1*28</i> Patient Genotype

Rossana Roncato, Erika Cecchin, Marcella Montico et al. · Clinical Pharmacology & Therapeutics · 2017 · 37 citations

Colorectal Surgery, Epidemiology Of Cancer, Care Folfiri +25

Analytical aspects of sunitinib and its geometric isomerism towards therapeutic drug monitoring in clinical routine

Bianca Posocco, Mauro Buzzo, Luciana Giodini et al. · Journal of Pharmaceutical and Biomedical Analysis · 2018 · 29 citations

Therapeutic Drug Monitoring, Medicinal Chemistry, Analytical Aspects +13